LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC

被引:37
作者
Niu, Limin [1 ,2 ]
Fan, Qingxia [1 ]
Yan, Min [2 ,3 ]
Wang, Liuxing [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China
[3] Henan Canc Hosp, Dept Breast Surg, Zhengzhou 450008, Henan, Peoples R China
关键词
NEGATIVE BREAST-CANCER; LONG NONCODING RNAS; FEATURES;
D O I
10.1042/BSR20190468
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NRON mediates the degradation of tat protein to participate in HIV-1 infection. Interestingly, our study observed the down-regulation of NRON in triple-negative breast cancer (TNBC) tissues compared with paired adjacent healthy tissues. In contrast, lncRNA snaR was up-regulated in TNBC tissues and was inversely correlated with NRON. Expression levels of snaR increased, while expression levels of NRON decreased along with the increase of clinical stages. The snaR overexpression resulted in promoted cancer cell proliferation but did not significantly affect NRON expression. NRON overexpression inhibited cancer cell proliferation and down-regulated snaR. The snaR overexpression reduced the effects of NRON overexpression. We therefore conclude that NRON may down-regulate lncRNA snaR to inhibit cancer cell proliferation in TNBC.
引用
收藏
页数:6
相关论文
共 19 条
[1]   Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research [J].
Bosch, Ana ;
Eroles, Pilar ;
Zaragoza, Rosa ;
Vina, Juan R. ;
Lluch, Ana .
CANCER TREATMENT REVIEWS, 2010, 36 (03) :206-215
[2]  
Böttcher R, 2015, ONCOTARGET, V6, P4036
[3]   Triple-negative breast cancer: disease entity or title of convenience? [J].
Carey, Lisa ;
Winer, Eric ;
Viale, Giuseppe ;
Cameron, David ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (12) :683-692
[4]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434
[5]   Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression [J].
Engreitz, Jesse M. ;
Ollikainen, Noah ;
Guttman, Mitchell .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (12) :756-770
[6]   Triple-Negative Breast Cancer [J].
Foulkes, William D. ;
Smith, Ian E. ;
Reis-Filho, Jorge S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) :1938-1948
[7]   Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets [J].
Gupta, Subash Chandra ;
Tripathi, Yashoda Nandan .
INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (09) :1955-1967
[8]   The hallmarks of cancer A long non-coding RNA point of view [J].
Gutschner, Tony ;
Diederichs, Sven .
RNA BIOLOGY, 2012, 9 (06) :703-719
[9]   Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells [J].
Lee, Jeeyeon ;
Jung, Jin Hyang ;
Chae, Yee Soo ;
Park, Ho Yong ;
Kim, Wan Wook ;
Lee, Soo Jung ;
Jeong, Jae-Hwan ;
Kang, Seung Hee .
ANTICANCER RESEARCH, 2016, 36 (12) :6289-6295
[10]   Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation [J].
Li, Jun ;
Chen, Cancan ;
Ma, Xiancai ;
Geng, Guannan ;
Liu, Bingfeng ;
Zhang, Yijun ;
Zhang, Shaoyang ;
Zhong, Fudi ;
Liu, Chao ;
Yin, Yue ;
Cai, Weiping ;
Zhang, Hui .
NATURE COMMUNICATIONS, 2016, 7